These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37398872)

  • 1. Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Murphy G; Naughton A; Durand R; Heron E; McCaughey C; Murphy RT; Pearson I
    Interv Cardiol; 2023; 18():e14. PubMed ID: 37398872
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
    Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting balloons versus drug-eluting stents for small vessel coronary artery disease: a meta-analysis.
    Song CX; Zhou C; Hou W; Yin Y; Lu S; Liu G; Duan C; Li M; Zhang H
    Coron Artery Dis; 2020 May; 31(3):199-205. PubMed ID: 31833944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
    Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis comparing clinical effectiveness of drug-eluting stents, bare metal stents and coronary artery bypass surgery.
    Oh EH; Imanaka Y; Hayashida K; Kobuse H
    Int J Evid Based Healthc; 2007 Sep; 5(3):296-304. PubMed ID: 21631793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
    Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
    Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
    Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.
    Alfonso F; Pérez-Vizcayno MJ; Cuesta J; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Cequier A; Velázquez M; Moreno R; Mainar V; Domínguez A; Moris C; Molina E; Rivero F; Jiménez-Quevedo P; Gonzalo N; Fernández-Pérez C;
    JACC Cardiovasc Interv; 2018 May; 11(10):981-991. PubMed ID: 29798776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting balloons with provisional bail-out or adjunctive stenting in
    Patel S; Svermova T; Burke-Gaffney A; Bogle RG
    Cardiovasc Diagn Ther; 2018 Apr; 8(2):121-136. PubMed ID: 29850403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients.
    Giacoppo D; Gargiulo G; Aruta P; Capranzano P; Tamburino C; Capodanno D
    BMJ; 2015 Nov; 351():h5392. PubMed ID: 26537292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials.
    Jackson-Smith E; Zioupos S; Banerjee P
    Open Heart; 2022 Oct; 9(2):. PubMed ID: 36288820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery stents: a rapid systematic review and economic evaluation.
    Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T
    Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials.
    Elgendy IY; Mahmoud AN; Elgendy AY; Mojadidi MK; Elbadawi A; Eshtehardi P; Pérez-Vizcayno MJ; Wayangankar SA; Jneid H; David Anderson R; Alfonso F
    Cardiovasc Revasc Med; 2019 Jul; 20(7):612-618. PubMed ID: 30126824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
    Liu L; Liu B; Ren J; Hui G; Qi C; Wang J
    BMC Cardiovasc Disord; 2018 Mar; 18(1):46. PubMed ID: 29499651
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.